Sign in

ACCD on NYSE

Accolade

Accolade is a health technology company based in Philadelphia, founded in 2007.1 Its shares trade on NYSE under the symbol ACCD.1

Price unavailable

Last updated Oct 21, 2026.

Overview

$414.3MRevenue, fiscal 20244
-$99.8MNet income, fiscal 20244
2007Founded1

Compare with Rimini Street, Inc., Fiverr International Ltd. or Zhihu, or pick any stock.

  • TickerACCD on NYSE1
  • Industrymedical technology1
  • HeadquartersPhiladelphia1
  • Websitewww.accolade.com
  • Legal formDelaware corporation1
  • Listed onNasdaq (ACCD), New York Stock Exchange (ACCD)1
  • Incorporated inDE5
  • Business address660 W. Germantown Pike Suite 500, Plymouth Meeting, Pa 194625
  • Filer categoryLarge accelerated filer5
  • LEI549300PHKG8J7A22NF083
  • StatusActive3
  • LEI statusLapsed (not renewed)3
  • Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States3
  • Registered withDivision of Corporations, Department of State, 42898403

See how the biggest companies compare on our leaderboards

Accolade image from its website
Image: accolade.com7

You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Annual Report on Form 10-K primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors described in the section titled "Risk Factors" and elsewhere in this Annual Report on Form 10-K. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Annual Report on Form 10-K. The results, events, and cir…8 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

-27.6%Operating margin4
-24.1%Net margin4
14.1%Revenue growth, 20244
-22.4%Return on equity4
-$21.1MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Other costs100¢$413.1M
  • Income tax0¢$1.2M

Out of $414.3M in revenue.4 The company lost money this year.

Financial statements

Revenue910114$414.3M in 2024+337% since 2019
0$200.0M$400.0M$600.0M2019: $94.8M$94.8M20192020: $132.5M$132.5M2020+40%2021: $170.4M$170.4M2021+29%2022: $310.0M$310.0M2022+82%2023: $363.1M$363.1M2023+17%2024: $414.3M$414.3M2024+14%
Operating income910114-$114.5M in 2024+112% since 2019
-$600.0M-$400.0M-$200.0M02019: -$54.0M-$54.0M20192020: -$48.2M-$48.2M2020−11%2021: -$46.8M-$46.8M2021−3%2022: -$125.7M-$125.7M2022+169%2023: -$463.5M-$463.5M2023+269%2024: -$114.5M-$114.5M2024−75%
Net income910114-$99.8M in 2024+77% since 2019
-$600.0M-$400.0M-$200.0M02019: -$56.5M-$56.5M20192020: -$51.4M-$51.4M2020−9%2021: -$50.7M-$50.7M2021−1%2022: -$123.1M-$123.1M2022+143%2023: -$459.6M-$459.6M2023+273%2024: -$99.8M-$99.8M2024−78%
Fiscal year2018201920202021202220232024
Revenue$94.8M9$132.5M10$170.4M11$310.0M4$363.1M4$414.3M4
Operating expenses$266.7M4$627.8M4$306.5M4
Operating income-$54.0M9-$48.2M10-$46.8M11-$125.7M4-$463.5M4-$114.5M4
Income before tax-$128.8M4-$463.3M4-$98.6M4
Income tax$55.0K9$129.0K10$4.0K11-$5.6M4-$3.6M4$1.2M4
Net income-$56.5M9-$51.4M10-$50.7M11-$123.1M4-$459.6M4-$99.8M4
Earnings per share-$9.1310-$1.7211-$1.934-$6.454-$1.334
Earnings per share (diluted)-$9.1310-$1.7211-$1.934-$6.454-$1.334
Shares (weighted, basic)63.8M shares471.3M shares474.9M shares4
Shares (weighted, diluted)63.8M shares471.3M shares474.9M shares4

Compare Accolade with another company

Corporate structure

Accolade sits at the top of its group. 7 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Accolade

  • Accolade Seattle, Washington, United States
    • 1stMD LLC Subsidiary · Texas, United States
    • Accolade 2ndMD LLC Subsidiary · Texas, United States
    • Accolade Techologies s.r.o. Subsidiary · Czechia
    • MD Insider, Inc. Subsidiary · Delaware, United States
    • PlushCare Technologies Canada, Inc. Subsidiary · Canada
    • PlushCare, Inc. Subsidiary · Delaware, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Accolade reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$78.0M4 Feb 29, 2024$69.6M4 Feb 28, 2023+12.1%
Accumulated depreciation$58.9M4 Feb 29, 2024$54.8M4 Feb 28, 2023+7.4%
Property and equipment, net$19.1M4 Feb 29, 2024$14.8M4 Feb 28, 2023+29.6%
Operating-lease assets (leased space)$28.3M4 Feb 29, 2024$29.5M4 Feb 28, 2023−4.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$185.7M4 Feb 29, 2024$321.1M4 Feb 28, 2023−42.2%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$278.2M4 Feb 29, 2024$278.2M4 Feb 28, 20230%
Intangible assets, net (excluding goodwill)$165.4M4 Feb 29, 2024$203.2M4 Feb 28, 2023−18.6%
Finite-lived intangibles, gross$283.6M4 Feb 29, 2024$283.6M4 Feb 28, 20230%
Accumulated amortization$118.2M4 Feb 29, 2024$80.4M4 Feb 28, 2023+47.0%
Finite-lived intangibles, net$165.4M4 Feb 29, 2024$203.2M4 Feb 28, 2023−18.6%

Leadership

Who has led Accolade, and when. Pick a name to see everywhere that person has worked.

President

  1. Robert N. Cavanaugh2020–2025

Chief financial officer

  1. Stephen H. Barnes2020–2025
2010201520202025
Board members and other officers (13)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Officer, DirectorRajeev J. Singh named Oct 15, 202129

Products and brands

  • software

Listed on Wikidata.1

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • 1stMD LLC Texas6
  • Accolade 2ndMD LLC Texas6
  • Accolade Techologies s.r.o. Czech Republic6
  • MD Insider, Inc. Delaware6
  • PlushCare Technologies Canada, Inc. Canada6
  • PlushCare, Inc. Delaware6

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • Accolade LLCJan 21, 2010 to Jan 21, 20105

Timeline

  1. Apr 8, 20258-K Entered a material agreement; Completed an acquisition or sale; Listing notice or transfer30
  2. Mar 27, 20258-K Shareholder vote; Regulation FD disclosure31
  3. Jan 8, 20258-K Entered a material agreement; Results of operations; Regulation FD disclosure32
  4. Oct 8, 20248-K Results of operations33
  5. Aug 7, 20248-K Shareholder vote34
  6. Jun 27, 20248-K Results of operations35
  7. Apr 25, 20248-K Results of operations36
  8. Jan 8, 20248-K Results of operations37
  9. Nov 16, 20238-K Other events38
  10. Oct 4, 20238-K Results of operations39
  11. Aug 9, 20238-K Shareholder vote40
  12. Jun 29, 20238-K Results of operations41
  13. 2020Went public Listed on NYSE1
  14. 2007Founded Founded1

Calendar

When it reported results

  1. Jan 8, 2025Reported quarterly or annual results32
  2. Oct 8, 2024Reported quarterly or annual results33
  3. Jun 27, 2024Reported quarterly or annual results35
  4. Apr 25, 2024Reported quarterly or annual results36
  5. Jan 8, 2024Reported quarterly or annual results37
  6. Oct 4, 2023Reported quarterly or annual results39
  7. Jun 29, 2023Reported quarterly or annual results41
  8. Apr 27, 2023Reported quarterly or annual results42

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

822 filings to the SEC since October 2021: 3 annual reports, 11 quarterly reports, 23 major events, 475 insider forms, 32 large holders, 1 private raises, 277 other. The latest 20:

  1. Aug 13, 2025SCHEDULE 13G/A EDGAR
  2. May 15, 2025SCHEDULE 13G/A EDGAR
  3. May 14, 2025SCHEDULE 13G EDGAR
  4. May 14, 2025SCHEDULE 13G/A EDGAR
  5. May 9, 2025SCHEDULE 13G EDGAR
  6. Apr 18, 202515-12G EDGAR
  7. Apr 10, 2025SCHEDULE 13D/A EDGAR
  8. Apr 8, 20254 EDGAR
  9. Apr 8, 20254 EDGAR
  10. Apr 8, 20254 EDGAR
  11. Apr 8, 20254 EDGAR
  12. Apr 8, 20254 EDGAR
  13. Apr 8, 20254 EDGAR
  14. Apr 8, 20254 EDGAR
  15. Apr 8, 20254 EDGAR
  16. Apr 8, 20254 EDGAR
  17. Apr 8, 20254 EDGAR
  18. Apr 8, 20254 EDGAR
  19. Apr 8, 20254 EDGAR
  20. Apr 8, 2025S-8 POS EDGAR

The 822 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

290 open-market trades by officers, directors and large owners since October 2021: 3 buys and 287 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Apr 2, 2025Barnes Stephen H.Chief Financial OfficerSale431$6.99$3.0KForm 4
Apr 2, 2025Cavanaugh Robert NPresidentSale550$6.99$3.8KForm 4
Apr 2, 2025SINGH RAJEEVChief Executive OfficerSale922$6.99$6.4KForm 4
Apr 2, 2025Eskew RichardEVP General CounselSale378$6.99$2.6KForm 4
Mar 18, 2025SINGH RAJEEVChief Executive OfficerSale289$6.99$2.0KForm 4
Mar 18, 2025Barnes Stephen H.Chief Financial OfficerSale142$6.99$993Form 4
Mar 18, 2025Cavanaugh Robert NPresidentSale181$6.99$1.3KForm 4
Mar 11, 2025Cavanaugh Robert NPresidentSale249$6.97$1.7KForm 4
Mar 11, 2025Barnes Stephen H.Chief Financial OfficerSale254$6.97$1.8KForm 4
Mar 11, 2025SINGH RAJEEVChief Executive OfficerSale490$6.97$3.4KForm 4
Mar 4, 2025Barnes Stephen H.Chief Financial OfficerSale514$6.96$3.6KForm 4
Mar 4, 2025Cavanaugh Robert NPresidentSale550$6.96$3.8KForm 4
Mar 4, 2025SINGH RAJEEVChief Executive OfficerSale1,121$6.96$7.8KForm 4
Mar 4, 2025Eskew RichardEVP General CounselSale377$6.96$2.6KForm 4
Feb 19, 2025Cavanaugh Robert NPresidentSale180$6.90$1.2KForm 4
Feb 19, 2025Barnes Stephen H.Chief Financial OfficerSale137$6.90$945Form 4
Feb 19, 2025SINGH RAJEEVChief Executive OfficerSale279$6.90$1.9KForm 4
Feb 11, 2025SINGH RAJEEVChief Executive OfficerSale509$6.89$3.5KForm 4
Feb 11, 2025Cavanaugh Robert NPresidentSale252$6.89$1.7KForm 4
Feb 11, 2025Barnes Stephen H.Chief Financial OfficerSale221$6.89$1.5KForm 4

All 290 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$11.2M 2021–2021
Money received by yearMoney received by year, 2021–2021: $11.2M in all. Private raises (Form D) $11.2M.$0$5M$10M$15M2021 · Private raises (Form D): $11.2M2021
Figures by year
YearPrivate raises (Form D)Total
2021$11.2M$11.2M

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Sep 30, 2021Raised $11.2 million in a private offering of equity29 Form D: $12.5 million offered in all Form D

SEC filer profile

How Accolade is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAccolade, Inc.2
  • CIK0001481646
  • Employer ID (EIN)43-21178362
  • Filer statusLarge accelerated filer2
  • Incorporated inDelaware2
  • Fiscal year endsFebruary 282
  • Industry code (SIC)7389 Services-Business Services, NEC2
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance2
  • Business address660 W. Germantown Pike Suite 500, Plymouth Meeting, PA 194622
  • Phone610-834-29892
  • Shares outstanding81,585,508 as of Dec 31, 202413
  • Public float$926.1M as of Aug 31, 20234
  • On EDGAR sinceJan 21, 20102
  • Filings993 in all: 4 (520), 144 (249), 8-K (42), 3 (22), 10-Q (15), SC 13G/A (14), CORRESP (12), D (11)2
    All 47 form types

    UPLOAD (10), SC 13G (9), DEFA14A (8), EFFECT (5), S-1/A (5), S-8 (5), S-8 POS (5), SCHEDULE 13G/A (5), 10-K (4), 5 (4), DEF 14A (4), 4/A (3), S-1 (3), SCHEDULE 13G (3), 3/A (2), 424B4 (2), DRS (2), DRS/A (2), DRSLTR (2), POS AM (2), S-1MEF (2), SC 13D (2), SC 13D/A (2), SEC STAFF LETTER (2), 15-12G (1), 25-NSE (1), 424B3 (1), 424B7 (1), 8-A12B (1), 8-K/A (1), CERT (1), D/A (1), DEFM14A (1), NT 10-K (1), POS EX (1), PREM14A (1), S-3ASR (1), SCHEDULE 13D (1), SCHEDULE 13D/A (1)

  • Latest filingsAnnual report (10-K) Apr 26, 2024
    Quarterly report (10-Q) Jan 10, 2025
    Proxy statement (DEF 14A) Jun 21, 2024
    Latest 8-K (8-K) Apr 8, 2025

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
    Company websiteAccolade photo
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
    SEC EDGAROther events
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54